Investigation proves Pfizer vaccine offers less than 1%

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
568
Investigation proves Pfizer vaccine offers less than 1% protection against COVID-19

An investigation by the Canadian COVID Care Alliance (CCCA) has found that Pfizer’s Wuhan coronavirus (COVID-19) vaccine only has an efficacy rate of 0.84 percent. They added that Pfizer’s vaccine has done “more harm than good.”

The CCCA recently published a video and an accompanying 50-page PDF presentation that provides a thorough explanation of their investigation of the recent data released by Pfizer regarding the development and testing of the Big Pharma company’s COVID-19 vaccine.

The video and presentation explain that the CCCA is merely quantifying and contextualizing Pfizer’s claim that taking its COVID-19 vaccine is an act of risk reduction. When the Big Pharma company first unveiled its vaccine to the public, it claimed that it showed 95 percent efficacy seven days after the second dose.

But the CCCA said that the 95 percent efficacy is the reduction of “relative risk,” and not “absolute risk,” which the organization said is the more accurate scientific measurement to judge efficacy.

According to the absolute risk reduction value, Pfizer’s COVID-19 vaccine only has an efficacy rate of 0.84 percent.

In Pfizer’s trials for its COVID-19 vaccine, only eight out of 18,198 vaccinated participants were reported to have developed COVID-19. In the unvaccinated placebo group, 162 out of 18,325 developed COVID-19.

For the untrained eye, this data shows that getting Pfizer’s COVID-19 vaccine makes a person less likely to contract the virus. But the trial data shows that, even without the vaccine, the risk of contracting coronavirus was “extremely low,” at 0.88 percent for the unvaccinated and 0.04 percent for the vaccinated.

This is where Pfizer got its 95 percent number from. The company took the relative difference between the vaccinated and unvaccinated groups.

But when taking all of the trial data into consideration, the actual net benefit, or absolute risk, of taking Pfizer’s COVID-19 vaccine is just 0.84 percent.

“How many people would have chosen to take the COVID-19 vaccines had they understood that they offered less than one percent overall benefit?” asked the CCCA. “It’s clear that Pfizer – and the agencies overseeing their trials – failed to follow established, high quality safety and efficacy protocols right from the beginning.”

Pfizer vaccine increases risk of illness
Pfizer’s trial data also proves that getting vaccinated increases a person’s risk of illness.

According to the organization, Pfizer’s six-month trial data showed a “level one evidence of harm.” It found that around 91.3 percent of people in the vaccinated group experienced adverse reactions to the experimental vaccine. “There’s no benefit to a reduction in cases if it comes at a cost of increased illness and death,” said the CCCA.

There was a 300 percent increase in the number of adverse events determined to have been caused by the dangerous vaccine in the vaccinated group. Severe adverse events, or side effects that can strongly interfere with a person’s ability to function normally, increased by 75 percent in the vaccinated group.

There was also a 10 percent increase in serious adverse events among the vaccinated. A serious adverse event involves hospitalization or a visit to a hospital’s emergency room. (Related: Pfizer buys pharmaceutical company that makes heart medication to solve the problem caused by mRNA vaccines.)

Furthermore, more people in the vaccinated group died than in the placebo group – 20 to 14.

“Any government that approved this medical intervention for its citizens should have ensured that the trial had used the appropriate clinical endpoints and high quality safety science,” said the CCCA. “Any government official who possesses this evidence and continues to allow its citizens to be inoculated with a toxic agent is, at the very least, negligent.”

Watch the CCCA’s entire presentation proving that Pfizer’s COVID-19 vaccines do more harm than good.

video: https://newstarget.com/2022-01-17-pfizer-vacc...covid.html

This video is from the KristallKlar channel on Brighteon.com.

Learn more about how dangerous Pfizer’s COVID-19 vaccines are by reading the latest articles at Vaccines.news.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Empirik.ai's $21M for AI in Infrastructure Revolution

Updated Category News Views 3

AI-Powered Infrastructure Takes the Stage Well, here's a tech gambit going full steam: empirik.ai just hit the digital scene with a $21 million war chest. Fresh out of the stealth shadows, they've got big names like Sequoia Capital, S32, Canapi Ventures, and Alumni Ventures stamping their ticket. What's the fuss? They're rolling out the first AI agent designed to...

Continue Reading
Epson & The Photo Managers Highlight Memories in Sept.

Updated Category News Views 8

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

Continue Reading
ZPMC Names Two New 38,000 DWT Vessels for Chipolbrok

Updated Category News Views 5

Navigating Uncharted Waters with New Vessels Some days, you see a giant leap in an industry and think, "Well, someone's got ambition." Here, we're talking about ZPMC's gutsy naming ceremony for two spanking new 38,000 DWT multipurpose heavy-lift ships destined for Chipolbrok, happening fresh off the docks in Shanghai. Specifications That Make Waves Imagine a vessel the...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Balázs Nagy's Bold Move: Transforming AI Workforce

Updated Category News Views 0

New Horizons in AI: Balázs Nagy Leads There's always that one name that shakes things up, and today it's Balázs Nagy. The guy's not just playing in the AI sandbox; he's leveling the whole thing up with Project NoéMI. He's the big cheese at TheNewPush LLC, beyond just a job title. Nagy’s diving headfirst into AI workforce development in a world screaming for change....

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 0

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading
Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Updated Category News Views 5

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Behavioral Crisis Center Saves Mobile $101M Since 2021

Updated Category News Views 0

AltaPointe Saves Millions While Supporting Community Health Let's dig into this remarkable achievement by the AltaPointe Behavioral Health Crisis Center. Since opening its doors in May 2021, the Mobile, Alabama facility has notched up a mind-boggling $101.5 million in community savings. This isn’t merely about numbers on a ledger—it's about real human impact, better...

Continue Reading
SCO at 25: China's Strategic Push for Regional Growth

Updated Category News Views 7

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Collaboration Between Enthusiast Gaming and Frigo Cheese Heads

Updated Category News Views 116

Enthusiast Gaming Teams Up with Frigo Cheese Heads Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leader in gaming media and entertainment, has announced an exciting new partnership with Frigo Cheese Heads, the widely-loved string cheese brand from Saputo. This collaboration aims to engage fans with various sponsored...

Continue Reading
Bullen Ultrasonics: A Precision Manufacturing Force

Updated Category News Views 24

Precision in Every Detail at Bullen Ultrasonics When you start seeing accolades like the IndustryWeek Best Plants Awards, you know someone's doing something right. Bullen Ultrasonics in Eaton, Ohio, is giving the world a run for its money in advanced manufacturing, having cemented itself as one of six finalists for 2026. This isn't just a gold star for effort; it's...

Continue Reading
Recognizing Top Property Managers: Obligo's 2024 Awards

Updated Category News Views 125

Obligo Unveils Renter's Trust Awards for 2024 In an exciting announcement, Obligo showcases the leaders in property management through its fifth annual Renter's Trust Awards. This initiative highlights the companies that prioritize tenant experiences, ensuring that renting is not just a transaction but an enriching journey. Understanding the Importance of Trust in Rental...

Continue Reading
Unlocking the Secrets of Men's Fat Burners for Weight Loss

Updated Category News Views 323

Revolutionizing Weight Loss: Discovering Effective Men's Fat Burners In recent years, the landscape of dietary supplements has evolved significantly, especially for men seeking assistance in their weight loss journey. Wolfson Brands has launched an impressive new line of fat-burning supplements tailored to meet the unique challenges men face when trying to lose weight....

Continue Reading
Stellaromics Unveils Pyxa Platform for Advanced Cancer Research

Updated Category News Views 263

Stellaromics Launches Pyxa Platform in Europe Stellaromics, a trailblazer in the field of 3D spatial biology, has announced the deployment of its innovative Pyxa platform in Europe. This development underscores the company's commitment to advancing oncology research through groundbreaking technologies. Dr. Nigel Jamieson and his team from the University of Glasgow are the...

Continue Reading